These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10525078)

  • 1. Mechanisms of action of OPC-28326, a selective hindlimb vasodilator.
    Orito K; Imaizumi T; Yoshida K; Fujiki H; Kishi M; Teramoto S; Tanaka M; Shimizu H; Tominaga M; Kimura Y; Kambayashi J; Mori T
    J Pharmacol Exp Ther; 1999 Nov; 291(2):604-11. PubMed ID: 10525078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. alpha(2)-adrenoceptor antagonist properties of OPC-28326, a novel selective peripheral vasodilator.
    Orito K; Kishi M; Imaizumi T; Nakazawa T; Hashimoto A; Mori T; Kambe T
    Br J Pharmacol; 2001 Oct; 134(4):763-70. PubMed ID: 11606316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OPC-28326, a selective femoral vasodilator, is an alpha2C-adrenoceptor-selective antagonist.
    Sun B; Lockyer S; Li J; Chen R; Yoshitake M; Kambayashi JI
    J Pharmacol Exp Ther; 2001 Nov; 299(2):652-8. PubMed ID: 11602678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oral OPC-28326, a selective femoral arterial vasodilator, on hindlimb subcutaneous tissue temperature in conscious dogs under buprenorphine sedation.
    Orito K; Imaizumi T; Yoshida K; Kishi M; Fujiki H; Mori T
    Jpn J Pharmacol; 2002 Jan; 88(1):119-22. PubMed ID: 11855671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OPC-28326, a selective femoral arterial vasodilator, augments ischemia induced angiogenesis.
    Sumi M; Sata M; Hashimoto A; Imaizumi T; Yanaga K; Ohki T; Mori T; Nagai R
    Biomed Pharmacother; 2007 May; 61(4):209-15. PubMed ID: 17223008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
    Hirohashi M; Takasuna K; Yamashita N; Tamura K
    Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of alpha 2-adrenoceptors in the vasculature of the rat tail.
    Redfern WS; MacLean MR; Clague RU; McGrath JC
    Br J Pharmacol; 1995 Apr; 114(8):1724-30. PubMed ID: 7599941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of cardiovascular effects of SGB-1534 and prazosin, selective alpha 1-adrenoceptor antagonists, in anesthetized dogs.
    Imagawa J; Nabata H; Sakai K
    Jpn J Pharmacol; 1987 May; 44(1):35-41. PubMed ID: 2887683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of human recombinant alpha(2A)-adrenoceptors expressed in Chinese hamster lung cells using intracellular Ca(2+) changes: evidence for cross-talk between recombinant alpha(2A)- and native alpha(1)-adrenoceptors.
    Reynen PH; Martin GR; Eglen RM; MacLennan SJ
    Br J Pharmacol; 2000 Apr; 129(7):1339-46. PubMed ID: 10742289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonidine-induced nitric oxide-dependent vasorelaxation mediated by endothelial alpha(2)-adrenoceptor activation.
    Figueroa XF; Poblete MI; Boric MP; Mendizábal VE; Adler-Graschinsky E; Huidobro-Toro JP
    Br J Pharmacol; 2001 Nov; 134(5):957-68. PubMed ID: 11682443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential antagonism of alpha-1 and alpha-2 adrenoceptor-mediated pressor responses by urotensin I, a selective mesenteric vasodilator peptide.
    Bolt GR; Itoh H; Lederis K; MacCannell KL
    J Pharmacol Exp Ther; 1987 Jul; 242(1):284-91. PubMed ID: 3039111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurogenic double-peaked vasoconstriction of human gastroepiploic artery is mediated by both alpha1- and alpha2-adrenoceptors.
    Fukui D; Yang XP; Chiba S
    Br J Pharmacol; 2005 Mar; 144(6):737-42. PubMed ID: 15685216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of alpha-1 and alpha-2 adrenoceptor-mediated vasoconstriction in the in situ, autoperfused, pulmonary circulation of the anesthetized dog.
    Shebuski RJ; Fujita T; Ruffolo RR
    J Pharmacol Exp Ther; 1986 Jul; 238(1):217-23. PubMed ID: 3014116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenergic mechanisms in canine hindlimb circulation.
    Brungardt JM; Swan KG; Reynolds DG
    Cardiovasc Res; 1974 May; 8(3):423-9. PubMed ID: 4153267
    [No Abstract]   [Full Text] [Related]  

  • 15. Postsynaptic alpha-adrenoceptor subtypes in the internal carotid, mesenteric, splenic, renal and femoral vascular beds of the dog.
    Polonia JJ; Guerreiro M; Guimarães S; Garrett J
    Arch Int Pharmacodyn Ther; 1986 Jan; 279(1):5-16. PubMed ID: 3008676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptors involved in moxonidine-stimulated atrial natriuretic peptide release from isolated normotensive rat hearts.
    Mukaddam-Daher S; Menaouar A; Gutkowska J
    Eur J Pharmacol; 2006 Jul; 541(1-2):73-9. PubMed ID: 16774751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the role of alpha-1 and alpha-2 adrenoceptors in the maintenance of neurogenic tone to the hindlimb vasculature.
    Hamed AT; Jandhyala BS; Lokhandwala MF
    J Pharmacol Exp Ther; 1986 Aug; 238(2):599-605. PubMed ID: 3016243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of alpha 2-adrenergic and serotonergic receptor antagonists on cyclic blood flow alterations in stenosed canine coronary arteries.
    Bush LR; Campbell WB; Kern K; Tilton GD; Apprill P; Ashton J; Schmitz J; Buja LM; Willerson JT
    Circ Res; 1984 Nov; 55(5):642-52. PubMed ID: 6488486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of piperidine and its related substances on blood vessels.
    Aisaka K; Hattori Y; Ishihara T; Morita M; Kasé Y; Miyata T
    Jpn J Pharmacol; 1985 Apr; 37(4):345-53. PubMed ID: 4010086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of effects of urapidil and prazosin on vascular influence of circulating and neuronally released catecholamines in canine muscle vascular bed.
    Zeigler DW; Zimmerman BG
    J Cardiovasc Pharmacol; 1985; 7(6):1020-6. PubMed ID: 2418283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.